Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)

Conditions: Arrhythmogenic Right Ventricular Cardiomyopathy Sponsors: Tenaya Therapeutics; University of California, San Francisco; Brigham and Women ' s Hospital; New York University; University of Colorado, Denver; Johns Hopkins University; The Cleveland Clinic; Mayo Clinic; Medical University of South Carolina; Hopital Louis Pradel; Istituti Clinici Scientifici Maugeri SpA; The Queen Elizabeth Hospital; St George ' s University Hospitals NHS Foundation Trust; Royal Brompton& Harefield NHS Foundation Trust; Barts& The London NHS Trust Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials